GENOME-RESOLVED EVIDENCE

GCA_025643675.1

Clostridium perfringens · Complete Genome

View versioned NCBI assembly →

Assembly

ASM2564367v1

BioProject PRJNA562729 · BioSample SAMN12648941

Quality metadata

Genome size 3192184 bp · GC 28.500%

Completeness 31.050% · contamination 2.790%

Pathway marker completeness

ModuleMarkersFractionCall
bcd_etf_module0/30.000Partial/absent
ethanol_entry_support0/10.000Partial/absent
fatty_acid_biosynthesis_core0/80.000Partial/absent
lactate_entry_support0/20.000Partial/absent
reverse_beta_oxidation_core1/40.250Partial/absent
rnf_complex0/60.000Partial/absent

Detected markers

MarkerFunctionCopies
crtcrotonase/enoyl-CoA hydratase2

Profile-HMM marker predictions

Approved candidates and review records are genomic predictions, not evidence of expression or MCFA production. Excluded matches remain visible for audit.

Marker / proteinConfidenceReview statusScore / coverageSupporting evidence
No profile-HMM predictions for this assembly.

Protein-level evidence

GeneProteinOrthogroupCoordinatesAnnotation
crtF1C14_09490UXZ09523.1OG0001394CP043681.1:2019453–2020226 -short-chain-enoyl-CoA hydratase [Clostridium perfringens]
crtF1C14_12265UXZ09635.1OG0001639CP043681.1:2581656–2582426 +crotonase [Clostridium perfringens]

These are genomic annotation predictions. Experimental activity, expression and metabolite production require separate evidence.